Skip to main content
. Author manuscript; available in PMC: 2017 Jul 27.
Published in final edited form as: Int J Tuberc Lung Dis. 2014 Sep;18(9):1026–1033. doi: 10.5588/ijtld.13.0749

Figure 2.

Figure 2

Trends in first-line anti-tuberculosis drug resistance among new patients in Botswana’s national anti-tuberculosis drug resistance surveys, 1995–2008. INH =isoniazid; RMP =rifampicin; EMB = ethambutol; SM = streptomycin.